Perron flags stroke drug's potential in Alzheimer's treatment
Research by the Perron Institute has found that the flagship product of Perth-based neurological drug developer Argenica Therapeutics, which protects brain tissue from dying immediately after a stroke, may also help treat Alzheimer's disease.
Read original article on Business News - Latest Headlines →Related news
-
Woman admits ex-lover's stabbing murder mid-trial
-
WA Government orders coronial inquest into murders of Margaret Hawke’s three children in Port Hedland in 2022
-
RBA governor Michele Bullock pockets $1.2m pay package as rate pain continues
-
Cancer survivor killed by stepson a 'devoted father'
-
Gas industry urged to pull 'emergency brake' on warming
-
Auckland striker drops f-bombs in ban 'loophole' tirade
-
Opinion: There’s no place like home
-
Triple Tiger flag winner joins Dockers, Mzungu promoted